Cancer Research Aziza Shad  Genetics and Biology of Brain Cancer
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 47, 4345-4350, August 15, 1987]
© 1987 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Borrebaeck, C. A. K.
Right arrow Articles by Schön, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Borrebaeck, C. A. K.
Right arrow Articles by Schön, A.

Antiproliferative Response of Human Leukemic Cells: Lectin Induced Inhibition of DNA Synthesis and Cellular Metabolism1

Carl A. K. Borrebaeck2 and Arne Schön

Department of Biotechnology [C. A. K. B.] and Department of Thermochemistry [A. S.], University of Lund, P.O. Box 124, S-221 00 Lund, Sweden

Proliferation and DNA synthesis of human acute (CCRF-CEM, MOLT-4, JM, T-45) and chronic (SKW-3) lymphocytic leukemia cell lines of T-cell type were inhibited in a dose dependent fashion by the isolectins of phytohemagglutinin (PHA). PHA isolectin with four L subunits (PHA-L4) induced a significant antiproliferative response of CCRF-CEM and MOLT-4 tumor cells at a concentration of only 0.05 µg/ml. A 50% inhibition of DNA synthesis of these two cell lines was obtained at 0.4 and 0.5 µg PHA-L4/ml, respectively. The effect was cytostatic rather than cytotoxic. Considerably higher (>10) concentrations of PHA isolectin with four E subunits were needed to induce similar growth inhibition of the tumor cells, as compared to PHA-L4.

The effect of PHA isolectins on cellular metabolism of the leukemic cell lines was measured using microcalorimetry. The rate of heat production (thermal power), which is the net effect of all metabolic pathways, was decreased already after a 30-min culture of tumor cells in the presence of isolectin. PHA-L4 showed a significant inhibitory effect at a concentration of 0.1 µg/ml, whereas approximately 200 times more of PHA isolectin with four E subunits was needed to obtain the same metabolic inhibition. Measurements of glycolytic lactate and oxygen consumption during isolectin treatments supported the fact that the PHA-L4 induced antiproliferative response of human leukemic cell lines was specific and energy dependent. Six and three membrane components involved in the antiproliferative response of CCRF-CEM (ALL) and SKW-3 (CLL) cells, respectively, were isolated by affinity chromatography and characterized by electrophoresis.

1 This investigation was supported by a grant from the Swedish Cancer Society.

2 To whom requests for reprints should be addressed.

Received 10/20/86. Revised 1/28/87. Revised 5/ 6/87. Accepted 5/14/87.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1987 by the American Association for Cancer Research.